Zdrowie i gospodarka · 30/08/2019
FDA Reopens Submission Period for Modernizing Pharmaceutical Quality Systems
The FDA is extending the submission period for a notice on modernizing pharmaceutical quality systems, allowing more time for public participation in the Quality Metrics Feedback Program.
Source: Federal Register — Food and Drug AdministrationOpen original release →